Mergers & Acquisitions - Bristol-Myers Squibb, Anti-virals

Filter

Popular Filters

Bristol-Myers to buy hep C drug developer for $2.5 billion

09-01-2012

Looking to bolster its drug pipeline in the face of US patent expiry of one of its best selling drugs,…

Anti-viralsBristol-Myers SquibbInhibitexMergers & AcquisitionsPharmaceutical

Back to top